HDAC8 and cardiac hypertrophy: This study demonstrated that the HDAC8 selective inhibitor PCI34051 alleviated cardiac hypertrophy, pulmonary congestion, inflammation, and fibrosis, which resulted in improved cardiac functions in the pressure overload-induced heart failure mouse model.